Vertex Pharmaceuticals, Inc. (VRTX)
503.25
-2.39
(-0.47%)
USD |
NASDAQ |
Oct 08, 16:00
504.18
+0.93
(+0.18%)
Pre-Market: 20:00
Vertex Pharmaceuticals 30-Day Average Daily Volume : 1.013M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.013M |
| October 07, 2026 | 991353.6 |
| October 06, 2026 | 990293.5 |
| October 05, 2026 | 990040.9 |
| October 02, 2026 | 995369.4 |
| October 01, 2026 | 999463.0 |
| September 30, 2026 | 1.008M |
| September 29, 2026 | 1.019M |
| September 28, 2026 | 1.033M |
| September 25, 2026 | 1.044M |
| September 24, 2026 | 1.047M |
| September 23, 2026 | 1.051M |
| September 22, 2026 | 1.046M |
| September 21, 2026 | 1.089M |
| September 18, 2026 | 1.092M |
| September 17, 2026 | 1.044M |
| September 16, 2026 | 1.061M |
| September 15, 2026 | 1.107M |
| September 14, 2026 | 1.130M |
| September 11, 2026 | 1.134M |
| September 10, 2026 | 1.146M |
| September 09, 2026 | 1.167M |
| September 08, 2026 | 1.192M |
| September 04, 2026 | 1.209M |
| September 03, 2026 | 1.224M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.241M |
| September 01, 2026 | 1.226M |
| August 31, 2026 | 1.238M |
| August 28, 2026 | 1.235M |
| August 27, 2026 | 1.258M |
| August 26, 2026 | 1.276M |
| August 25, 2026 | 1.287M |
| August 24, 2026 | 1.298M |
| August 21, 2026 | 1.311M |
| August 20, 2026 | 1.323M |
| August 19, 2026 | 1.358M |
| August 18, 2026 | 1.386M |
| August 17, 2026 | 1.412M |
| August 14, 2026 | 1.426M |
| August 13, 2026 | 1.450M |
| August 12, 2026 | 1.469M |
| August 11, 2026 | 1.493M |
| August 10, 2026 | 1.526M |
| August 07, 2026 | 1.726M |
| August 06, 2026 | 1.744M |
| August 05, 2026 | 1.761M |
| August 04, 2026 | 1.755M |
| August 03, 2026 | 1.756M |
| July 31, 2026 | 1.805M |
| July 30, 2026 | 1.824M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.503M |
| Gilead Sciences, Inc. | 5.591M |
| Sionna Therapeutics, Inc. | 1.356M |
| Regeneron Pharmaceuticals, Inc. | 720681.1 |
| Ionis Pharmaceuticals, Inc. | 3.893M |